StockData
Haemonetics Corp logo

Haemonetics Corp (HAE) KPIs and segments

HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q2 FY2027, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3064% above fair value
$122.94+0.23 (+0.19%)

Close on Nov 13, 2026Market cap $5.59BP/E 54.9Yield –

KPIs & segments

Operating metrics and segments that drive Haemonetics's business

Haemonetics's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Haemonetics's fiscal year ends March 28 — Q1 FY27 = CQ2 2026 (calendar quarter).

Periods
Add to chartMetric
Q1 FY27
CQ2 2026
Q4 FY26
CQ1 2026
Q3 FY26
CQ4 2025
Q2 FY26
CQ3 2025
Q1 FY26
CQ2 2025
Q4 FY25
CQ1 2025
Q3 FY25
CQ4 2024
Q2 FY25
CQ3 2024
Q1 FY25
CQ2 2024
Q4 FY24
CQ1 2024
Q3 FY24
CQ4 2023
Q2 FY24
CQ3 2023
Apheresis($M)2
191182
Plasma products and services($M)
156145
Other($M)
35.836.7
Hospital($M)1
160144145140148144138134
Hospital($M)
144145140148144138134132116106
Med Surg($M)2
148140
Blood Management Technologies($M)
88.181.2
Interventional Technologies($M)
59.958.5
Plasma($M)1
130139125130127134139136
Plasma products and services($M)
130139125130127134139136139148143
Blood Center($M)1
56.456.656.551.856.070.368.566.2
Blood Center($M)
56.656.551.856.070.368.566.272.072.469.7
Apheresis, Blood Center1
Blood Center($M)
56.456.656.151.854.355.454.349.154.552.655.0
Hemostasis Management, Hospital1
Hospital($M)
99.387.486.481.281.180.776.571.076.773.267.2
Vascular Closure, Hosptial1
Hospital($M)
60.456.159.158.566.863.361.963.055.143.038.5
Whole Blood, Blood Center1
Blood Center($M)
000.390.021.6915.014.217.217.519.814.7
Earlier reporting (last reported 2024)2
Earlier reporting (last reported 2024)1
United States($M)
258252248240242248258256249246251236
Europe($M)
45.552.948.343.040.942.344.242.047.245.137.038.7
Rest of Asia($M)
20.220.023.022.621.621.225.625.819.826.830.927.7
Japan($M)
12.918.418.118.013.616.116.216.413.716.514.815.0
Other($M)
2.993.111.813.682.812.774.945.276.569.152.650.43
Apheresis($M)
56.559.2
Plasma($M)
43.750.242.648.350.647.744.441.7-52.280.578.0
Hospital($M)
29.625.929.918.421.827.423.316.5-79.949.441.8
Med Surg($M)
22.718.4
Blood Center($M)
11.213.014.810.99.9214.315.812.8-38.927.727.3
Apheresis($M)
107106
Hospital($M)
10594.496.289.493.495.390.785.3
Med Surg($M)
97.789.4
Plasma($M)
75.982.172.380.079.475.672.870.6
Blood Center($M)
25.727.529.525.926.230.132.230.1
Remaining performance obligations (RPO)($M)
3136.635.53633.330.528.923.522

36 metrics have no data in the last 12 quarters — .

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-08-06.

See a number that looks wrong?